Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?

Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs). We therefore studied the possible harmful impact of immunogenic ABO blood groups antigens – genetically governed antigenic determinants – at...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moll, Guido, Hult, Annika, von Bahr, Lena, Alm, Jessica J., Heldring, Nina, Hamad, Osama A., Stenbeck-Funke, Lillemor, Larsson, Stella, Teramura, Yuji, Roelofs, Helene, Nilsson, Bo, Fibbe, Willem E., Olsson, Martin L., Le Blanc, Katarina
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890285/
https://ncbi.nlm.nih.gov/pubmed/24454787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0085040
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados